ALMB-0166

N/A

Report date: 2026/04/08 16:01:29
First In Class

Base Information

Drug NameALMB-0166
Drug Alias NameHumanised connexin-43 monoclonal antibodyHumanised gap junction 43 monoclonal antibodyALMB-0166
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGap junction alpha-1 protein inhibitors
TargetsGap junction alpha-1 protein
Therapy Area/IndicationsSpinal Cord InjuriesStrokeParkinson Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Enlemai Biotechnology Co LtdCSPC Pharmaceutical Group Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAlamab Therapeutics IncCSPC Pharmaceutical Group LtdShanghai Enlemai Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSpinal Cord InjuriesStrokeParkinson Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A